retatrutide ly3437943 parkinson's disease clinical trial Drugs that bind human receptors in a way that only triggers certain, specific signaling pathways (i.e. "biased agonism") offers potential for safer medications. In this study A Study of Retatrutide (LY3437943)

The active-controlled design adds methodological rigour over placebo-only Phase 2 trials

When activated, glucagon receptors increase energy expenditure through thermogenesis, promote lipolysis, which is the breakdown of stored fat, and enhance fatty acid oxidation in the liver

2000, pp

E., do Carmo, J

CrossRef Delivery of miRNAs to the adipose organ for metabolic health Karin Kornmueller, Ez-Zoubir Amri, Marcel Scheideler, Ruth Prassl Advanced Drug Delivery Reviews.2022

Thermogenesis increases noticeably, with some researchers reporting feeling warmer than usual, increased sweating during physical activity, and elevated resting metabolic rate